{"id":"celiprolol","rwe":[{"pmid":"41818895","year":"2026","title":"A new microphysiological platform to study the permeation of neuroactive agents across intestinal and brain barriers.","finding":"","journal":"Biofabrication","studyType":"Clinical Study"},{"pmid":"41377782","year":"2025","title":"Challenges in the Management of Patients with Vascular Ehlers-Danlos Syndrome: Lessons from three Clinical Cases.","finding":"","journal":"European journal of case reports in internal medicine","studyType":"Clinical Study"},{"pmid":"40559232","year":"2025","title":"The Impact of Celiprolol in Vascular Ehlers-Danlos Syndrome: A Systematic Review of Current Evidence.","finding":"","journal":"Medical sciences (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"40280085","year":"2025","title":"Rapid quantification of 21 antihypertensive and diuretic drugs in plasma by UPLC-MS/MS: Application to clinical and forensic cases.","finding":"","journal":"Journal of pharmaceutical and biomedical analysis","studyType":"Clinical Study"},{"pmid":"40220705","year":"2025","title":"Significance of gut breast cancer resistance protein versus organic anion transporting polypeptide 2B1 inhibition on rosuvastatin clinical drug-drug interactions.","finding":"","journal":"Drug metabolism and disposition: the biological fate of chemicals","studyType":"Clinical Study"}],"tags":[{"label":"celiprolol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Beta-1 adrenergic receptor","category":"target"},{"label":"ADRB1","category":"gene"},{"label":"ADRB2","category":"gene"},{"label":"C07AB08","category":"atc"},{"label":"Active","category":"status"},{"label":"Angina pectoris","category":"indication"},{"label":"Hypertensive disorder","category":"indication"},{"label":"Adrenergic Agents","category":"pharmacology"},{"label":"Adrenergic Antagonists","category":"pharmacology"},{"label":"Adrenergic beta-1 Receptor Antagonists","category":"pharmacology"},{"label":"Adrenergic beta-Antagonists","category":"pharmacology"},{"label":"Anti-Arrhythmia Agents","category":"pharmacology"},{"label":"Antihypertensive Agents","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"},{"label":"Sympathomimetics","category":"pharmacology"},{"label":"Vasodilator Agents","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":90.503,"date":"","count":11,"signal":"Nipple inflammation","source":"DrugCentral FAERS","actionTaken":"Reported 11 times (LLR=91)"},{"llr":69.664,"date":"","count":11,"signal":"Nipple disorder","source":"DrugCentral FAERS","actionTaken":"Reported 11 times (LLR=70)"},{"llr":60.41,"date":"","count":61,"signal":"Acute kidney injury","source":"DrugCentral FAERS","actionTaken":"Reported 61 times (LLR=60)"},{"llr":48.698,"date":"","count":6,"signal":"Prevertebral soft tissue swelling of cervical space","source":"DrugCentral FAERS","actionTaken":"Reported 6 times (LLR=49)"},{"llr":48.304,"date":"","count":34,"signal":"Hyponatraemia","source":"DrugCentral FAERS","actionTaken":"Reported 34 times (LLR=48)"},{"llr":46.538,"date":"","count":30,"signal":"Bradycardia","source":"DrugCentral FAERS","actionTaken":"Reported 30 times (LLR=47)"},{"llr":44.265,"date":"","count":20,"signal":"Hepatocellular injury","source":"DrugCentral FAERS","actionTaken":"Reported 20 times (LLR=44)"},{"llr":44.249,"date":"","count":20,"signal":"Eosinophilia","source":"DrugCentral FAERS","actionTaken":"Reported 20 times (LLR=44)"},{"llr":41.132,"date":"","count":14,"signal":"Pemphigoid","source":"DrugCentral FAERS","actionTaken":"Reported 14 times (LLR=41)"},{"llr":37.303,"date":"","count":10,"signal":"Hypoglycaemic coma","source":"DrugCentral FAERS","actionTaken":"Reported 10 times (LLR=37)"},{"llr":36.513,"date":"","count":20,"signal":"Lactic acidosis","source":"DrugCentral FAERS","actionTaken":"Reported 20 times (LLR=37)"},{"llr":35.891,"date":"","count":11,"signal":"Aplasia","source":"DrugCentral FAERS","actionTaken":"Reported 11 times (LLR=36)"},{"llr":34.846,"date":"","count":6,"signal":"Wrong patient","source":"DrugCentral FAERS","actionTaken":"Reported 6 times (LLR=35)"},{"llr":34.733,"date":"","count":11,"signal":"Breast pain","source":"DrugCentral FAERS","actionTaken":"Reported 11 times (LLR=35)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CELIPROLOL","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:16:09.270204+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:16:16.145001+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CELIPROLOL","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:16:16.476373+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Beta-1 adrenergic receptor antagonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:16:17.565759+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL27810/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:16:17.215110+00:00"}},"allNames":"selectol","offLabel":[],"synonyms":["celiprolol","DL-Celiprolol","selectol","celiprolol hydrochloride","celiprolol HCl","celiprolol monohydrochloride"],"timeline":[{"date":"1982-01-01","type":"positive","source":"DrugCentral","milestone":"YEAR INTRODUCED approval"}],"brandName":"Selectol","ecosystem":[{"indication":"Angina pectoris","otherDrugs":[{"name":"amlodipine","slug":"amlodipine","company":"Pfizer"},{"name":"atenolol","slug":"atenolol","company":"Alvogen Ipco Sarl"},{"name":"atorvastatin","slug":"atorvastatin","company":"Pfizer"},{"name":"bepridil","slug":"bepridil","company":""}],"globalPrevalence":112000000},{"indication":"Hypertensive disorder","otherDrugs":[{"name":"acebutolol","slug":"acebutolol","company":"Promius Pharma"},{"name":"aliskiren","slug":"aliskiren","company":"Novartis"},{"name":"amiloride","slug":"amiloride","company":"Paddock Llc"},{"name":"amlodipine","slug":"amlodipine","company":"Pfizer"}],"globalPrevalence":null}],"mechanism":{"target":"Beta-1 adrenergic receptor","targets":[{"gene":"ADRB1","source":"DrugCentral","target":"Beta-1 adrenergic receptor","protein":"Beta-1 adrenergic receptor"},{"gene":"ADRB2","source":"DrugCentral","target":"Beta-2 adrenergic receptor","protein":"Beta-2 adrenergic receptor"}],"modality":"Small Molecule","drugClass":"celiprolol","explanation":"","oneSentence":"","technicalDetail":"Celiprolol selectively blocks the beta-1 adrenergic receptors in the heart, reducing the heart rate and contractility, and increasing the heart's sensitivity to catecholamines, which ultimately leads to a decrease in myocardial oxygen demand."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/569","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CELIPROLOL","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CELIPROLOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:21:20.671800","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:16:18.831941+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"metoprolol","drugSlug":"metoprolol","fdaApproval":"1978-08-07","patentExpiry":"Jul 9, 2035","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"atenolol","drugSlug":"atenolol","fdaApproval":"1981-08-19","genericCount":22,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"acebutolol","drugSlug":"acebutolol","fdaApproval":"1984-12-28","genericCount":3,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"betaxolol","drugSlug":"betaxolol","fdaApproval":"1985-08-30","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"bisoprolol","drugSlug":"bisoprolol","fdaApproval":"1992-07-31","genericCount":13,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"esmolol","drugSlug":"esmolol","fdaApproval":"1986-12-31","patentExpiry":"Mar 15, 2033","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"nebivolol","drugSlug":"nebivolol","fdaApproval":"2007-12-17","genericCount":18,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"celiprolol","indications":{"approved":[{"name":"Angina pectoris","source":"DrugCentral","snomedId":194828000,"regulator":"FDA","usPrevalence":null,"globalPrevalence":112000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2023"},{"name":"Hypertensive disorder","source":"DrugCentral","snomedId":38341003,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"metoprolol","brandName":"metoprolol","genericName":"metoprolol","approvalYear":"1978","relationship":"same-class"},{"drugId":"atenolol","brandName":"atenolol","genericName":"atenolol","approvalYear":"1981","relationship":"same-class"},{"drugId":"acebutolol","brandName":"acebutolol","genericName":"acebutolol","approvalYear":"1984","relationship":"same-class"},{"drugId":"betaxolol","brandName":"betaxolol","genericName":"betaxolol","approvalYear":"1985","relationship":"same-class"},{"drugId":"bisoprolol","brandName":"bisoprolol","genericName":"bisoprolol","approvalYear":"1992","relationship":"same-class"},{"drugId":"esmolol","brandName":"esmolol","genericName":"esmolol","approvalYear":"1986","relationship":"same-class"},{"drugId":"nebivolol","brandName":"nebivolol","genericName":"nebivolol","approvalYear":"2007","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT05432466","phase":"PHASE3","title":"Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome","status":"RECRUITING","sponsor":"Acer Therapeutics Inc.","startDate":"2022-11-07","conditions":["Vascular Ehlers-Danlos Syndrome"],"enrollment":150,"completionDate":"2029-04-01"},{"nctId":"NCT02380053","phase":"PHASE4","title":"Chronic Beta-blockade and Cardiopulmonary Exercise in COPD","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2016-06-07","conditions":["Chronic Obstructive Pulmonary Disease"],"enrollment":10,"completionDate":"2019-04-30"},{"nctId":"NCT03752931","phase":"PHASE2","title":"Celiprolol Versus Ditiazem for the Prevention of Postoperative Cardiac Arrythmias in Thoracic Surgery","status":"UNKNOWN","sponsor":"Abderrahmane Mami Hospital","startDate":"2018-12","conditions":["Postoperative Cardiac Complication"],"enrollment":30,"completionDate":"2020-12"},{"nctId":"NCT00190411","phase":"PHASE4","title":"Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2003-10","conditions":["EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT","CHROMOSOME 2q31.2 DELETION SYNDROME"],"enrollment":54,"completionDate":"2011-04"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000171770","NDDF":"003948","UNII":"DRB57K47QC","VUID":"4025238","CHEBI":"CHEBI:94461","VANDF":"4025238","INN_ID":"3979","RXNORM":"203145","UMLSCUI":"C0055021","chemblId":"CHEMBL27810","ChEMBL_ID":"CHEMBL27810","KEGG_DRUG":"D01741","DRUGBANK_ID":"DB04846","PUBCHEM_CID":"2663","SNOMEDCT_US":"349901006","IUPHAR_LIGAND_ID":"9064","SECONDARY_CAS_RN":"57470-78-7","MESH_DESCRIPTOR_UI":"D017272"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"40%"},"publicationCount":527,"therapeuticAreas":["Cardiovascular"],"atcClassification":{"source":"DrugCentral","atcCode":"C07AB08","allCodes":["C07AB08"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 25","pmid":"41818895","title":"A new microphysiological platform to study the permeation of neuroactive agents across intestinal and brain barriers.","journal":"Biofabrication"},{"date":"2025","pmid":"41377782","title":"Challenges in the Management of Patients with Vascular Ehlers-Danlos Syndrome: Lessons from three Clinical Cases.","journal":"European journal of case reports in internal medicine"},{"date":"2025 Jun 9","pmid":"40559232","title":"The Impact of Celiprolol in Vascular Ehlers-Danlos Syndrome: A Systematic Review of Current Evidence.","journal":"Medical sciences (Basel, Switzerland)"},{"date":"2025 Sep 15","pmid":"40280085","title":"Rapid quantification of 21 antihypertensive and diuretic drugs in plasma by UPLC-MS/MS: Application to clinical and forensic cases.","journal":"Journal of pharmaceutical and biomedical analysis"},{"date":"2025 Apr","pmid":"40220705","title":"Significance of gut breast cancer resistance protein versus organic anion transporting polypeptide 2B1 inhibition on rosuvastatin clinical drug-drug interactions.","journal":"Drug metabolism and disposition: the biological fate of chemicals"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:16:18.831941+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}